[vc_section][vc_row][vc_column][vc_single_image image=”77259″ img_size=”full”][vc_column_text]

A living biobank of matched patient-derived cancer models from in vitro to in vivo for cancer pharmacology

Atlantis Bioscience is organizing a webinar titled “A living biobank of matched patient-derived cancer models from in vitro to in vivo for cancer pharmacology” on 25 Feb 2022 at 2.30pm. The purpose of this webinar is to introduce tumour organoids as an excellent predictive in vitro model for translational research. Tumour organoids are developed using Hubrecht Organoid Technology (HUB) protocols to faithfully recapitulate original patient tissue histo- and molecular pathology. Matched in vitro patient-derived organoids (PDXO) and in vivo PDX model pairs provide a unique preclinical workflow with improved predictivity and a more rapid and informed study transition to accelerate your drug discovery programs.

[/vc_column_text][vc_cta h2=”We would be glad if you could join and participate. To save your seat, please register” h2_font_container=”font_size:21|color:%233f3f3f” h2_google_fonts=”font_family:Lato%3A100%2C100italic%2C300%2C300italic%2Cregular%2Citalic%2C700%2C700italic%2C900%2C900italic|font_style:700%20bold%20regular%3A700%3Anormal” style=”custom” add_button=”right” btn_title=”REGISTER” btn_style=”classic” btn_color=”black” btn_size=”lg” btn_i_icon_fontawesome=”fas fa-edit” use_custom_fonts_h2=”true” btn_add_icon=”true” btn_link=”url:https%3A%2F%2Fus02web.zoom.us%2Fwebinar%2Fregister%2F5016443052676%2FWN_rt3g3sF0RGKid2C6V_PbOQ|target:_blank” custom_background=”#e5e5e5″ custom_text=”#000000″][/vc_cta][/vc_column][/vc_row][/vc_section]